150 related articles for article (PubMed ID: 38427060)
21. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
22. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
Satou A; Tabata T; Suzuki Y; Sato Y; Tahara I; Mochizuki K; Oishi N; Takahara T; Yoshino T; Tsuzuki T; Nakamura S
Virchows Arch; 2021 May; 478(5):969-976. PubMed ID: 33169195
[TBL] [Abstract][Full Text] [Related]
23. NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
Boztug H; Hirschmugl T; Holter W; Lakatos K; Kager L; Trapin D; Pickl W; Förster-Waldl E; Boztug K
J Clin Immunol; 2016 Aug; 36(6):533-40. PubMed ID: 27338827
[TBL] [Abstract][Full Text] [Related]
24. Immunoregulatory T cells in males vulnerable to Epstein-Barr virus with the X-linked lymphoproliferative syndrome.
Lai PK; Yasuda N; Purtilo DT
Am J Pediatr Hematol Oncol; 1987; 9(2):179-82. PubMed ID: 3035958
[TBL] [Abstract][Full Text] [Related]
25. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
[TBL] [Abstract][Full Text] [Related]
26. Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity.
Rooney CM; Smith CA; Heslop HE
Mol Med Today; 1997 Jan; 3(1):24-30. PubMed ID: 9021739
[TBL] [Abstract][Full Text] [Related]
27. Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription.
Rothenberger S; Bachmann E; Berger C; McQuain C; Odermatt BF; Knecht H
Oncogene; 1997 May; 14(17):2123-6. PubMed ID: 9160892
[TBL] [Abstract][Full Text] [Related]
28. EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.
Ok CY; Li L; Young KH
Exp Mol Med; 2015 Jan; 47(1):e132. PubMed ID: 25613729
[TBL] [Abstract][Full Text] [Related]
29. Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge.
Costagliola G; Consolini R
Clin Exp Immunol; 2021 Sep; 205(3):288-305. PubMed ID: 34008169
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus lymphoproliferative disease of donor origin after kidney transplantation: a case report.
Renoult E; Aymard B; Grégoire MJ; Bellou A; Hubert J; Hestin D; Audouin J; Lederlin P; Kessler M
Am J Kidney Dis; 1995 Jul; 26(1):84-7. PubMed ID: 7611274
[TBL] [Abstract][Full Text] [Related]
31. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
Sullivan JL; Byron KS; Brewster FE; Baker SM; Ochs HD
J Clin Invest; 1983 Jun; 71(6):1765-78. PubMed ID: 6306053
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report.
Zheng X; Xie J; Zhou X
Int J Clin Exp Pathol; 2015; 8(7):8598-602. PubMed ID: 26339440
[TBL] [Abstract][Full Text] [Related]
33. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
Tanner JE; Alfieri C
Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
[TBL] [Abstract][Full Text] [Related]
34. Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection.
Ishihara S; Tawa A; Yumura-Yagi K; Murata M; Hara J; Yabuuchi H; Hirai K; Kawa-Ha K
Jpn J Cancer Res; 1989 Feb; 80(2):99-101. PubMed ID: 2542204
[TBL] [Abstract][Full Text] [Related]
35. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
Guinness ME; Kenney JL; Reiss M; Lacy J
Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
[TBL] [Abstract][Full Text] [Related]
37. In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations.
Weiss LM; Movahed LA
Am J Pathol; 1989 Mar; 134(3):651-9. PubMed ID: 2538060
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
Xu ZG; Iwatsuki K; Ohtsuka M; Oyama N; Matsui T; Kaneko F
J Med Virol; 2000 Oct; 62(2):239-46. PubMed ID: 11002254
[TBL] [Abstract][Full Text] [Related]
39. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors.
Rea D; Delecluse HJ; Hamilton-Dutoit SJ; Marelle L; Joab I; Edelman L; Finet JF; Raphael M
Ann Oncol; 1994; 5 Suppl 1():113-6. PubMed ID: 8172807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
